Jean-Paul Kress – Biography

Last update: April 23, 2026

Executive profile

Jean-Paul was President and Chief Executive Officer at Syntimmune, and Executive Vice President, President International and Head of Global Therapeutic Operations at Biogen. Jean-Paul Kress joined Sanofi in 2024.

Jean-Paul Kress is currently

Create your alert
to follow the career of Jean-Paul Kress.

Education

Jean-Paul Kress has a Medical Doctor from Université René Descartes (Paris V) and a Master of Science in Molecular And Cellular Pharmacology from École normale supérieure.

They have also studied at Université René Descartes (Paris V) :

Find more alumni from Université René Descartes (Paris V)


They have also studied at École normale supérieure :

Find more alumni from École normale supérieure

The colleagues of Jean-Paul Kress

Company Colleagues
Industry Colleagues
  • In the Pharmaceuticals industry, Jean-Paul Kress has 22,991 colleagues in 1,914 companies located in 68 countries. 10,852 executive movements have been recorded in the last 12 months. Learn more about Pharmaceuticals.

Report an error
Update the org chart details of Jean-Paul Kress.

Get in Touch

Here are a few tips for establishing great contacts.

Through the switchboard,
and ask for Jean-Paul Kress.

Share

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.